Companies: 10,795·Total market cap: $144.5T
FOXO Technologies Inc.

FOXO Technologies Inc.

FOXOOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2999
P/E Ratio
52W High$0.46765
52W Low$0.0001

FOXO Technologies Inc. (FOXO) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

FOXO · free cash flow · updated Jun 15, 2026

Core FCF metrics

Free cash flow was −$3.9M for FY2025 (fiscal year ending 2025-12-31), down 38.2% year-over-year The FCF margin was -24.0%.

FY2025 Free Cash Flow−$3.9M▼ -38.2% YoY
Trailing 12M (TTM)−$2.5Mtrailing 4 quarters sum
FCF Margin-24.0%−$3.9M ÷ revenue
3-Year CAGRN/AN/A — contains negative FCF
5-Year CAGRN/AN/A — contains negative FCF
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
foxo free cash flow history · foxo free cash flow chart · foxo free cash flow growth rate · foxo free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest−$3.9M▼ 38.2%-24.0%
FY2024−$2.8M▲ +57.3%-70.1%
FY2023−$6.6M▲ +74.1%
FY2022−$25.6M▼ 67.5%
FY2021−$15.3M▼ 3077.5%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
foxo free cash flow 2025 · foxo free cash flow 2024 · foxo free cash flow 2023 · foxo operating cash flow

FCF valuation metrics

FOXO Technologies Inc. (FOXO) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)
N/A
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
N/A
TTM FCF ÷ Shares Outstanding
Price / FCF
N/A
Share Price ÷ FCF per Share
EV / FCF (TTM)
N/A
Enterprise Value basis
!

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31
foxo price to free cash flow · foxo free cash flow yield · foxo free cash flow per share · foxo price to cash flow ratio

Cash flow statement summary

For FY2025, FOXO Technologies Inc. generated −$3.9M in operating cash flow and spent 0M in capital expenditures, yielding −$3.9M in free cash flow.

Operating Activities
−$3.9M
Cash from core business operations
2025-12-31
Investing Activities
−$0.7M
CapEx, acquisitions & investments
2025-12-31
Financing Activities
+$4.7M
Buybacks, dividends & debt
2025-12-31
FCF FormulaOperating CF (−$3.9M) − |CapEx| (0M) = FCF (−$3.9M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
foxo cash flow statement · foxo cash flow statement 2025 · foxo operating cash flow · foxo cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
FOXO Technologies Inc.
FOXO Technologies Inc.YOU
FOXO
−$3.9M-38.2%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

FOXO Technologies Inc. (FOXO) reported free cash flow of −$3.9M for FY2025 (fiscal year ending 2025-12-31), down 38.2% year-over-year. The FCF margin was -24.0%.

FOXO Technologies Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 6 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

FOXO free cash flow · 8 questions

FOXO Technologies Inc. free cash flow was −$3.9M for FY2025, down 38.2% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$2.5M.

FOXO free cash flowFOXO FCFFOXO FCF 2025FOXO free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · FOXO Technologies Inc. · FOXO Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026